Aleco D’andrea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aleco D’andrea has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bruno Amati
European Institute of Oncology (IEO)—IRCCS Milan Italy
1 shared publication Daniela Olivero
Laboratorio Analisi Veterinarie BiEsseA, Via A. d'Aosta 7, 20129 Milan, Italy
1 shared publicationGiulio Donati
Department of Experimental Oncology, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy
1 shared publication- Ilaria Gritti
Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, USA
1 shared publication - Marco Giorgio
Department of Biomedical Sciences, University of Padua, Via Ugo Bassi 58/B, 35131 Padova, Italy
1 shared publication - Micol Ravà
Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
1 shared publication
Latest Publications
- 31 January 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (426)
Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC / BCL2 double-hit B cell lymphoma
The antibiotic tigecycline and the BCL2 inhibitor venetoclax cooperate to treat MYC/BCL2 double-hit lymphomas in xenografted mice.
- 31 January 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (426)
Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC / BCL2 double-hit B cell lymphoma
The antibiotic tigecycline and the BCL2 inhibitor venetoclax cooperate to treat MYC/BCL2 double-hit lymphomas in xenografted mice.